These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7489307)

  • 21. [Differentiation between benign and malignant breast lesions using fat-suppressed dynamic MR imaging].
    Koshiishi T; Isomoto I; Nakamura K; Kajiwara Y; Izawa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jul; 58(8):433-40. PubMed ID: 9745257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Technics for the preoperative marking of nonpalpable breast lesions in MRT].
    Sittek H; Kessler M; Müller-Lisse U; Untch M; Bohmert H; Reiser M
    Rofo; 1996 Jul; 165(1):84-7. PubMed ID: 8765369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dynamic 3D MR mammography using a rapid gradient-echo sequence].
    Müller-Schimpfle M; Rieber A; Kurz S; Stern W; Claussen CD
    Rofo; 1995 Jan; 162(1):13-9. PubMed ID: 7841394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of time-intensity curves in ductal carcinoma in situ (DCIS) and mastopathy obtained using dynamic contrast-enhanced magnetic resonance imaging.
    Nishiura M; Yasuhiro T; Murase K
    Magn Reson Imaging; 2011 Jan; 29(1):99-105. PubMed ID: 20833496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage.
    Stomper PC; Herman S; Klippenstein DL; Winston JS; Budnick RM; Stewart CC
    Cancer; 1996 May; 77(9):1844-9. PubMed ID: 8646683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnostic value of ADC and rADC of diffusion weighted imaging in malignant breast lesions].
    Xie CM; Yin SH; Li H; Liu XW; Zhang Y; Lü YC; Zhang R; Li JP; Geng ZJ; Wu PH
    Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):217-20. PubMed ID: 20450592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [MR mammography in patients at risk].
    Kaiser WA; Mittelmeier O
    Rofo; 1992 Jun; 156(6):576-81. PubMed ID: 1617179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T].
    Kuhl CK; Kreft BP; Hauswirth A; Gieseke J; Elevelt A; Reiser M; Schild HH
    Rofo; 1995 Jun; 162(6):482-91. PubMed ID: 7605960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The marking of nonpalpable breast tumors in MRT].
    Schmitt R; Helmberger T; Fellner F; Obletter N
    Rofo; 1993 Nov; 159(5):484-6. PubMed ID: 8219146
    [No Abstract]   [Full Text] [Related]  

  • 30. [Contrast enhancement of the nipple in nuclear magnetic resonance tomography of the breast with Gd-DTPA].
    Beck R; Heywang SH; Eiermann W; Permanetter W; Lissner J
    Digitale Bilddiagn; 1987 Dec; 7(4):167-9. PubMed ID: 3436118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy.
    Baltzer PA; Dietzel M; Vag T; Burmeister H; Gajda M; Camara O; Pfleiderer SO; Kaiser WA
    Rofo; 2011 May; 183(5):441-7. PubMed ID: 21318935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
    Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
    Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Magnetic resonance tomography of the breast. The results of 253 examinations].
    Kaiser WA
    Dtsch Med Wochenschr; 1989 Sep; 114(36):1351-7. PubMed ID: 2776660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostic value of preoperative contrast-enhanced MR imaging of the breast].
    Winnekendonk G; Krug B; Warm M; Göhring UJ; Mallmann P; Lackner K
    Rofo; 2004 May; 176(5):688-93. PubMed ID: 15122467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Contrast media in MR mammography].
    Tontsch P; Bauer M; Birmelin G; von Landenberg E; Moeller TB; Raible G
    Aktuelle Radiol; 1997 Mar; 7(2):86-92. PubMed ID: 9172669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MR imaging of the breast with Gd-DTPA: use and limitations.
    Heywang SH; Wolf A; Pruss E; Hilbertz T; Eiermann W; Permanetter W
    Radiology; 1989 Apr; 171(1):95-103. PubMed ID: 2648479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CE-Magnetic Resonance Mammography for the evaluation of the contralateral breast in patients with diagnosed breast cancer.
    Pediconi F; Venditti F; Padula S; Roselli A; Moriconi E; Giacomelli L; Catalano C; Passariello R
    Radiol Med; 2005; 110(1-2):61-8. PubMed ID: 16163140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential of MR mammography to predict tumor grading of invasive breast cancer.
    Dietzel M; Baltzer PA; Vag T; Zoubi R; Gröschel T; Burmeister H; Gajda M; Runnebaum IB; Kaiser WA
    Rofo; 2011 Sep; 183(9):826-33. PubMed ID: 21442559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast lesion localization: a freehand, interactive MR imaging-guided technique.
    Daniel BL; Birdwell RL; Ikeda DM; Jeffrey SS; Black JW; Block WF; Sawyer-Glover AM; Glover GH; Herfkens RJ
    Radiology; 1998 May; 207(2):455-63. PubMed ID: 9577495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A prototype double coil for MR breast measurement].
    Kaiser WA; Kess H
    Rofo; 1989 Jul; 151(1):103-5. PubMed ID: 2546196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.